magnetic confinement fusion.
approach to generating fusion power that uses magnetic fields to confine fuel
Dyne Reports One-Year DM1 Trial Improvements
Dyne Therapeutics reported one-year Phase 1/2 ACHIEVE trial data showing sustained improvements in measures of myotonia, muscle strength, mobility and patient-reported health among people with myotonic dystrophy type 1 taking investigational z-basivarsen. The company said the treatment had a favorable safety profile; registrational expansion results are expected in 2027 and could support a U.S. accelerated approval application.
Health · 8 sources · Oct 1, 2026Read itThe journal
Open the journal →The conversation starts in the journal — be the first to post.
About magnetic confinement fusion
Magnetic confinement fusion (MCF) is an approach to generate thermonuclear fusion power that uses magnetic fields to confine fusion fuel in the form of a plasma. Magnetic confinement is one of two major branches of controlled fusion research, along with inertial confinement fusion.
Everything about magnetic confinement fusion →